Sana Biotechnology (NASDAQ:SANA) Trading Up 5.7% - MarketBeat

1 day ago · Sana Biotechnology (NASDAQ:SANA - Get Free Report) last announced its quarterly earnings results on Friday, November 8th. The company reported ($0.25) earnings per share …

7%
OFF

Sana Biotechnology (NASDAQ:SANA) Trading Up 5.7% - MarketBeat

2 weeks from now

1 day ago · Sana Biotechnology (NASDAQ:SANA - Get Free Report) last announced its quarterly earnings results on Friday, November 8th. The company reported ($0.25) earnings per share …

marketbeat.com

7%
OFF

Sana Biotechnology (NASDAQ:SANA) Trading Up 5.7% - MarketBeat

2 weeks from now

3 days ago · Sana Biotechnology, Inc. (NASDAQ:SANA - Get Free Report)'s stock price shot up 5.7% on Monday . The company traded as high as $4.01 and last traded at $3.87. 2,159,066 …

marketbeat.com

200%
OFF

Sana Biotech Stock Jumps On Cell Therapy Data (SANA:NASDAQ)

2 weeks from now

Jan 8, 2025 · Sana Biotechnology (NASDAQ:SANA) climbed over 200% on Wednesday following a sharp rally in the post-market yesterday in reaction to a Phase 1 readout for its UP421 cell …

seekingalpha.com

00%
OFF

Sana Biotechnology, Inc. (SANA) Stock Forecast & Price Prediction …

2 weeks from now

Jan 8, 2025 · Sana Biotechnology, Inc. (SANA) Stock Price Prediction & Forecast 2025. At the start of 2025, the SANA stock was at $4.49. Today, it is trading at $4.49, which is 0.00% …

bullishbrokers.com

$4.30
OFF

Sana Biotechnology (NASDAQ:SANA) Shares Gap Up - MarketBeat

2 weeks from now

6 days ago · Sana Biotechnology, Inc. (NASDAQ:SANA - Get Free Report)'s share price gapped up before the market opened on Friday . The stock had previously closed at $4.30, but opened …

marketbeat.com

$2.65
OFF

HC Wainwright Boosts Sana Biotechnology (NASDAQ:SANA

2 weeks from now

Jan 8, 2025 · Get Our Latest Research Report on Sana Biotechnology. Sana Biotechnology Stock Performance. Shares of Sana Biotechnology stock traded up $2.65 during trading on …

marketbeat.com

$3.21
OFF

Sana Biotechnology (NASDAQ:SANA) Upgraded To "Buy" At TD …

2 weeks from now

Jan 8, 2025 · Shares of NASDAQ:SANA traded up $3.21 during mid-day trading on Wednesday, hitting $4.86. 146,860,124 shares of the company traded hands, compared to its average …

marketbeat.com

FAQs about Sana Biotechnology (NASDAQ:SANA) Trading Up 5.7% - MarketBeat Coupon?

Why did Sana biotechnology stock soared after Phase 1 data?

Sana Biotechnology (SANA) stock soared after Phase 1 data for its cell therapy which, according to Morgan Stanley, has de-risked its HIP platform. Read more here. ...

Where can I buy Sana biotechnology stock?

Shares of SANA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Sana Biotechnology own? ...

Why did Sana biotechnology (Sana) rise 200%?

Sana Biotechnology (NASDAQ: SANA) climbed over 200% on Wednesday following a sharp rally in the post-market yesterday in reaction to a Phase 1 readout for its UP421 cell therapy, which, according to Morgan Stanley, has de-risked the company's hypoimmune (HIP) therapeutic platform. ...

How much did Sana biotechnology IPO cost?

Sana Biotechnology (SANA) raised $322 million in an initial public offering (IPO) on Thursday, February 4th 2021. The company issued 15,000,000 shares at $20.00-$23.00 per share. Morgan Stanley, Goldman Sachs, J.P. Morgan and BofA Securities served as the underwriters for the IPO. How do I buy shares of Sana Biotechnology? ...

Where is Sana biotechnology headquartered?

Sana Biotechnology, Inc. was incorporated in 2018 and is headquartered in Seattle, Washington. Read More… Sana Biotechnology scored higher than 46% of companies evaluated by MarketBeat, and ranked 655th out of 957 stocks in the medical sector. ...

What does Sana biotechnology do?

Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. It develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, B-cell-mediated autoimmune, and others. ...